Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society [1] (multiple letters)

Neurology

Volumn 64, Issue 1, 2005, Pages 172-174

  Holloway, Robert G ^a   French, Jacqueline A ^a   Kanner, Andres ^a   Gronseth, Gary ^a   Krauss, Gregory L ^a   Panayiotopoulos, C P ^a   Benbadis, S R ^a   Covanis, A ^a   Dulac, O ^a   Duncan, J S ^a   Eeg Olofsson, O ^a   Ferrie, C D ^a   Grunewald R A ^a   Kasteleijn Nolst Trenite D G A ^a   Koutroumanidis, M ^a   Martinovic, Z ^a   Newton, R W ^a   Parker, A P J ^a   Salas Puig, J ^a   Sander, J W ^a   Shorvon, S ^a   Watanabe, K ^a   Whitehouse, W P ^a   Youroukos, S ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

DRUG EFFICACY; DRUG INDUSTRY; DRUG TOLERABILITY; EPILEPSY; ETHICS; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HUMAN; INTERPERSONAL COMMUNICATION; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; CONFLICT OF INTEREST; NOTE; OUTCOME ASSESSMENT; DIFFERENTIAL DIAGNOSIS; HEALTH CARE PLANNING; SEIZURE; CLINICAL TRIAL; STANDARD;

ANTICONVULSANTS; CONFLICT OF INTEREST; EPILEPSY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); DIAGNOSIS, DIFFERENTIAL; HEALTH PLANNING GUIDELINES; SEIZURES; CLINICAL TRIALS; FRUCTOSE; VALPROIC ACID;

EID: 19944428383     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.64.1.172     Document Type: Letter

References (0)